Our Partners.
Project LANTERN spans multiple cities across Europe. We are a consortium of esteemed partners, including the coordinating site Fondazione Policlinico Universitario “A. Gemelli” IRCCS in Italy (FPG), Technische Universität Dresden in Germany (TUD), University of Debrecen in Hungary (DEB), Hospital de la Santa Creu i Sant Pau in Catalonia, Spain (HSCSP), Koç University School of Medicine in Turkey (KU), and the EUPATI Expert Patient Academy (AdPEE) representing patient organizations.
Fondazione Policlinico Universitario “A. Gemelli” IRCCS in Italy (FPG)
Technische Universität Dresden in Germany (TUD)
University of Debrecen in Hungary (DEB)
Hospital de la Santa Creu i Sant Pau in Catalonia, Spain (HSCSP)
Koç University School of Medicine in Turkey (KU)
Our
Project
Get to Know Us
The LANTERN study, a groundbreaking European multi-center clinical trial, is redefining lung cancer management through the innovative integration of multi-omics data and Artificial Intelligence (AI). Coordinated by Fondazione Policlinico Universitario "A. Gemelli" IRCCS, LANTERN brings together leading institutions across Europe to create Digital Human Avatars (DHA) — detailed, data-driven digital representations of lung cancer patients.



